| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/24/2011 | CN102160869A Application of eleutheroside E in preparing medicines for resisting central fatigue |
| 08/24/2011 | CN102160865A Compositions of r(+) and s(-) pramipexole and methods of using the same |
| 08/24/2011 | CN102160857A Methylphenidate patch |
| 08/24/2011 | CN102160731A Health care pillow prepared from traditional Chinese medicine and preparation method and applications thereof |
| 08/24/2011 | CN102160685A Atomized caffeine and atomization method |
| 08/24/2011 | CN102160651A Stabilized formulations of phosphatidylserine |
| 08/24/2011 | CN101869660B Capsules for treating chronic fatigue syndrome and climacteric syndrome |
| 08/24/2011 | CN101829164B Biological preparation method of Hypericum perforatum L extractive |
| 08/24/2011 | CN101410385B Benzothiazoles having histamine H3 receptor activity |
| 08/24/2011 | CN101375954B Medicament composition, preparation method thereof and use |
| 08/24/2011 | CN101332258B Medicine composition with tranquilization function |
| 08/24/2011 | CN101166706B Hydroquinone long-chain derivative and/or phenoxy long-chain derivative, and pharmaceutical preparation comprising the same |
| 08/23/2011 | US8003772 Chimeric PUFA polyketide synthase systems and uses thereof |
| 08/23/2011 | US8003704 Tryptophan metabolite as aldehyde dehydrogenase inhibitor; side effect reduction |
| 08/23/2011 | US8003679 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril |
| 08/23/2011 | US8003669 Remedy for sleep disturbance |
| 08/23/2011 | US8003656 2-phenoxy pyrimidinone analogues |
| 08/23/2011 | US8003651 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| 08/23/2011 | US8003645 type II diabetes; 6-Ethyl-N,N'-bis(3-hydroxyphenyl)-1,3,5-triazine-2,4-diamine; suppress the fall in MTT reduction capacity by beta -amyloid protein; inhibit impairment of long-term potentiation of hippocampal nerve cells, pyrimidine or 1,3,5 triazine derivatives |
| 08/23/2011 | US8003643 Inhibitors of Akt activity |
| 08/23/2011 | US8003638 7-pyrazolylbenzazepines having affinity for D3 receptor |
| 08/23/2011 | US8003631 Composition and method for the treatment of tauopathies |
| 08/23/2011 | US8003615 Stable vitamin B6 derivative |
| 08/23/2011 | US8003351 Activatable recombinant neurotoxins |
| 08/23/2011 | US8003347 Nucleic acids encoding ChemerinR ligands |
| 08/23/2011 | CA2622541C Use of fluorinated triazoles for treating neuropathic pain |
| 08/23/2011 | CA2501772C Use of dihydroimidazolones for the treatment of epilepsy in dogs |
| 08/23/2011 | CA2492461C Fruit and/or vegetable derived composition |
| 08/23/2011 | CA2458632C Urea-compounds active as vanilloid receptor antagonists for the treatment of pain |
| 08/23/2011 | CA2442159C Treatment using neublastin polypeptides |
| 08/23/2011 | CA2377209C Therapeutic peptide-based constructs |
| 08/23/2011 | CA2335488C Conformationally constrained backbone cyclized somatostatin analogs |
| 08/23/2011 | CA2203888C Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 08/18/2011 | WO2011100550A2 Compositions and methods for treating depression |
| 08/18/2011 | WO2011100324A1 Cannabinoid receptor agonists |
| 08/18/2011 | WO2011099894A1 Agent which reduces the desire to smoke |
| 08/18/2011 | WO2011099570A1 Age production inhibitor |
| 08/18/2011 | WO2011099502A1 Use of compound binding to msin3b that specifically binds to neuron restrictive silencer factor (nrsf) |
| 08/18/2011 | WO2011099305A1 5-ht4 receptor agonists for the treatment of dementia |
| 08/18/2011 | WO2011098990A1 Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases |
| 08/18/2011 | WO2011098689A2 Use of agomelatine for the preparation of drugs for treating obsessive compulsive disorder (ocd) |
| 08/18/2011 | WO2011098539A1 Treatment of loss of sense of touch with saxitoxin derivatives |
| 08/18/2011 | WO2011098456A1 Safinamide in the treatment of dyskinesia |
| 08/18/2011 | WO2011098448A1 Use of isorhamnetin triglycosides |
| 08/18/2011 | WO2011097691A1 Composition containing resveratrol and/or derivatives thereof and plant oil, process for producing said composition, nutraceutical and/or pharmaceutical product, and method for enhancing the potential of resveratrol |
| 08/18/2011 | WO2011090740A9 Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1 |
| 08/18/2011 | WO2011080751A3 α4β2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS |
| 08/18/2011 | WO2011076867A3 Plant extracts for treating neurodegenerative diseases |
| 08/18/2011 | WO2011056930A9 Fragile x mental retardation protein (fmrp), compositions, and methods related thereto |
| 08/18/2011 | WO2011047341A3 Treatment of suicidal ideation or behavior using inhibitors of nicotinic acetylcholine receptors |
| 08/18/2011 | WO2011047277A3 Release of agents from cells |
| 08/18/2011 | WO2011044535A3 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
| 08/18/2011 | WO2011044264A9 Pyrrolopyrazoles for treating cns disorders |
| 08/18/2011 | WO2011044230A9 N-acetylcysteine amide (nac amide) for the treatment of diseases and conditions |
| 08/18/2011 | WO2010066253A8 Selective inhibitors of excitatory amino acid transporter subtype 1 (eaat1 /glast) |
| 08/18/2011 | US20110203007 Assays of neurodegenerative disorders, including frontotemporal dementia and amyotrophic lateral sclerosis |
| 08/18/2011 | US20110202000 Anti-amyloid beta antibodies conjugated to sialic acid-containing molecules |
| 08/18/2011 | US20110201817 Levodopa prodrugs, and compositions and uses thereof |
| 08/18/2011 | US20110201694 Compositions and Methods for Treatment of Disorders of Protein Aggregation |
| 08/18/2011 | US20110201686 Inhibitors of ASS and Synuclein Aggregation |
| 08/18/2011 | US20110201679 Use of Tocotrienols for Elevating IKBKAP Gene Expression and Treating Neurodegenerative Diseases or Disorders |
| 08/18/2011 | US20110201670 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases |
| 08/18/2011 | US20110201663 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists |
| 08/18/2011 | US20110201659 Agent for preventing or treating zoster-associated pain |
| 08/18/2011 | US20110201657 Amide substituted indazole and benzotriazole derivatives as poly(adp-ribose)polymerase (parp) inhibitors |
| 08/18/2011 | US20110201656 Novel diphenyl 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 08/18/2011 | US20110201655 Pharmaceutical composition improving intestinal absorption |
| 08/18/2011 | US20110201652 2,4-Disubstituted Pyrrolidine Orexin Receptor Antagonists |
| 08/18/2011 | US20110201650 Cyclohexane derivative and pharmaceutical use thereof |
| 08/18/2011 | US20110201646 Optical isomers of an iloperidone metabolite |
| 08/18/2011 | US20110201645 Method Of Treating Attention Deficit Disorders With D-Threo Methylphenidate |
| 08/18/2011 | US20110201643 Novel n-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds |
| 08/18/2011 | US20110201641 Indole derivatives as crth2 receptor antagonists |
| 08/18/2011 | US20110201636 Use of 14,15-dihydro-20,21-dinoreburnamenin-14-ol for the treatment and/or prevention of serious depression and sleep/waking cycle disorders |
| 08/18/2011 | US20110201632 2,5-Disubstituted Piperidine Orexin Rceptor Antagonists |
| 08/18/2011 | US20110201629 Cyclohexyl amide derivatives as crf receptor antagonists |
| 08/18/2011 | US20110201627 Freeze-dried reparation of tetrodotoxin and the producing method thereof |
| 08/18/2011 | US20110201626 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase |
| 08/18/2011 | US20110201623 Crystalline Form Of A Cyclopropyl Benzamide Derivative |
| 08/18/2011 | US20110201622 Solid Forms Comprising A Cyclopropyl Amide Derivative |
| 08/18/2011 | US20110201617 Therapeutic Uses Of Compounds Having Combined SERT, 5-HT3 And 5-HT1A Activity |
| 08/18/2011 | US20110201614 Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals |
| 08/18/2011 | US20110201612 Compositions for Modulating a Kinase Cascade and Methods of Use Thereof |
| 08/18/2011 | US20110201611 Process for the Preparation of Compositions for Modulating a Kinase Cascade and Methods of Use Thereof |
| 08/18/2011 | US20110201607 Fused heterocyclic m1 receptor positive allosteric modulators |
| 08/18/2011 | US20110201605 Heteroaryl substituted piperidines |
| 08/18/2011 | US20110201604 Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof |
| 08/18/2011 | US20110201601 Inhibitors of the shiga toxins trafficking through the retrograde pathway |
| 08/18/2011 | US20110201597 Method and composition for treating alzheimer-type dementia |
| 08/18/2011 | US20110201591 Isonicotinamide orexin receptor antagonists |
| 08/18/2011 | US20110201590 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof |
| 08/18/2011 | US20110201587 Hsp90 inhibitors and methods of use |
| 08/18/2011 | US20110201580 Pyrrolidine derivatives |
| 08/18/2011 | US20110201579 Method of Improving the Overall Health of a Patient by Application of Pregnenolone |
| 08/18/2011 | US20110201574 Fatty acid amide hydrolase inhibitors |
| 08/18/2011 | US20110201567 Ivermectin Antagonizes Ethanol Inhibition in P2X4 Receptors |
| 08/18/2011 | US20110201565 Luteolin and diosmin/diosmetin as novel stat3 inhibitors for treating autism |
| 08/18/2011 | US20110201558 Anaplerotic Therapy for Alzheimer's Disease and the Aging Brain |
| 08/18/2011 | US20110201557 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory |
| 08/18/2011 | US20110201555 Novel estrogen receptor ligands |